Healthcare

New Study Finds Endoscopy Equipment Market Worth $39.3 Billion

Markets and Markets Logo

According to the new market research report “Endoscopy Equipment Marketby Product (Endoscope (Flexible, Rigid, Capsule, Robot-assisted, Disposable), Visualization Systems, Accessories), Application (GI Endoscopy, Laparoscopy, Bronchoscopy, Arthroscopy), End User – Global Forecast to 2026″, published by MarketsandMarkets™, the global Endoscopy Equipment Market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. ...

Read More »

Geneoscopy Starts Clinical Trial for Home Colorectal-Cancer Test

ST. LOUIS, Missouri—Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the enrollment of its first patients in the CRC-PREVENT pivotal trial. The clinical study seeks to evaluate the safety and efficacy of Geneoscopy’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, including advanced adenomas, in average-risk individuals, a ...

Read More »

New Colorectal Cancer Screening Recommended to Begin at 45

The Colorectal Cancer Alliance (Alliance), a national nonprofit that exists to end colorectal cancer, today applauds the United States Preventive Services Task Force (USPSTF) for updating its colorectal cancer (CRC) screening guidelines in response to rising cases of CRC in younger adults. The new guidelines state that all people who are at average risk for the disease should begin screening for colorectal cancer at ...

Read More »

BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories

BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator. The product is used as an antiseptic for the preparation of the patient’s skin prior to surgery ...

Read More »

Companies Enter Partnership for Blood Test to Detect Colorectal Cancer and Pre-Cancer

SUNNYVALE, Calif., and ROSWELL, Ga.—CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, recently announced the closing of a strategic development and commercial collaboration agreement, as well as CellMax’s Series C financing. The financing will be used to accelerate the clinical development of CellMax’s multimodal ...

Read More »